US equities
|
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about DMT/Assisted Therapy
Recent news which mentions DMT/Assisted Therapy
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
Srinivas Rao
DMT Clinical Trial
VLS/01
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
Benzinga
Cannabis
AGNPF
From
Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
Tags
Legal
Psychedelics
Penny Stocks
From
Benzinga
How Certain Psychedelics Produce Brain And Behavior Changes: UCL Leads New Study
December 16, 2022
Tickers
DMTTF
Tags
Management
Markets
Top Stories
From
Benzinga